Severe Acute Respiratory Syndrome CoV 2 COVID-19 Survey and Vaccination Coverage in the Sickle Cell Population in Ile-De-France

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The objective of this study is to determine the seroprevalence of severe acute respiratory syndrome-CoV-2 in unvaccinated sickle cell patients living in an area with high viral circulation and at risk of high viral transmission, after the 4th epidemic wave of COVID-19 in Ile-de -France, over a period of 3 months (for example, last quarter of 2021).
Epistemonikos ID: 37f8ce40f8a25d98301a27f343dd0586b6e4c526
First added on: Dec 11, 2021